| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Fulfillment And Distribution |
|
Main Subject - Fulfillment And Distribution
The process of delivering the product to the customer is termed as distribution. Distrib According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ution management consists of two major tasks: physical distribution and management of di ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in tribution channels. Physical distribution can be defined as the process of reaching the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. product to the consumers. It encompasses all the activities involved in the physical flo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe of products from producers to consumers. It is physical distribution that provides pla d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e-utility and time-utility to a product. In other words, it is physical distribution tha ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t makes the product available at the right place and at the right time, thereby maximizi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi g the company’s chance to sell the product and strengthen its competitive position. If a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically product could be consumed at the place and time of production, there would be no need f and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ r distribution. Such products are rare. Almost every product gets consumed far away - b ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi th in time and space - from its point of manufacture. They have to be carried, stored an ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d distributed. In the case of some products, the location of the production points is to dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ally dictated by production considerations, like proximity to a port or to the source of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin raw material. In such cases, the production point may be far away from the market. Dis tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ribution aids the process of demand generation. It is distribution that largely determin t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s the customer service level. Through this, distribution serves as an effective tool for ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust building up of clientele/ market. And conversely, inefficient distribution leads to los y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products of customers and markets. Distribution is very important area for cost savings. Over t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de he years, in most businesses, distribution costs have grown into a sizeable chunk of the elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip total costs and now rank second among all cost elements, next only to the material costs tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How You Can Offer Your Clients Voice Mail without Having to Do All the Work Do You Want To Start A Photography Business?
|